Julien Viotti
University Institute Of The Face And Neck
Nice, France
Nice, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Metachronous second primary neoplasia in oropharyngeal cancer patients: Impact of tumor HPV status. A GETTEC multicentric study.
Journal: Oral oncology
Published: April 02, 2021
Therapeutic Drug Monitoring of Direct Oral Anticoagulants May Increase Their Benefit-Risk Ratio.
Journal: Journal of cardiovascular pharmacology
Published: October 08, 2020
Upfront surgery or definitive radiotherapy for p16+ oropharyngeal cancer. A GETTEC multicentric study.
Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published: September 28, 2020
Phase II study of concomitant radiotherapy with atezolizumab in oligometastatic soft tissue sarcomas: STEREOSARC trial protocol.
Journal: BMJ open
Published: September 24, 2020
Upfront surgery or definitive radiotherapy for patients with p16-negative oropharyngeal squamous cell carcinoma. A GETTEC multicentric study.
Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published: January 08, 2020
DPD status and fluoropyrimidines-based treatment: high activity matters too.
Journal: BMC cancer
Published: December 02, 2019
Identification of a new aggressive axis driven by ciliogenesis and absence of VDAC1-ΔC in clear cell Renal Cell Carcinoma patients.
Journal: Theranostics
Published: October 08, 2019
Preoperative breast imaging review: Interests and limits of specialized validation in oncology
Journal: Bulletin du cancer
Published: September 25, 2019
Iron deficiency during first-line chemotherapy in metastatic cancers: a prospective epidemiological study.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: December 07, 2018
Resistance to lysosomotropic drugs used to treat kidney and breast cancers involves autophagy and inflammation and converges in inducing CXCL5.
Journal: Theranostics
Published: August 08, 2018
Last Updated: 09/26/2026